-
Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment
Author: Liu, Xinyu; Shi, Jian; Wang, Deyang; Su, Ying; Xing, Zhen; Sun, Fei; Chen, Fei
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 1, pp. 13-22. DOI: 10.1007/s40261-022-01231-w
-
Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis
Author: Gao, Mengxia; Zhu, Lingqun; Chang, Jingling; Cao, Tianyu; Song, Lianying; Wen, Chunli; Chen, Yi; Zhuo, Yudi; Chen, Fei
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 1, pp. 1-11. DOI: 10.1007/s40261-022-01229-4
-
Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women
Author: Shao, Feng; Jiang, Yi; Ding, Sijia; Larsson, Per; Pinton, Philippe; Jonker, Daniel Martijn
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 1, pp. 37-44. DOI: 10.1007/s40261-022-01232-9
-
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study
Author: Deng, Haiyi; Deng, Jiating; Lin, Xinqing; Guan, Wenhui; Lin, Ziying; Qiu, Yanli; Yang, Yilin; Wu, Jianhui; Qiu, Guihuan; Sun, Ni; Zhou, Maolin; Deng, Jiaxi; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Qin, Yinyin; Zhou, Yanbin; Zhou, Chengzhi
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01267-6
-
A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects
Author: Jing, Shan; Shiba, Sari; Morita, Masafumi; Yasuda, Sanae; Lin, Yang
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 3, pp. 155-165. DOI: 10.1007/s40261-022-01241-8
-
Efficacy of Eltrombopag with Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone on Severe Aplastic Anaemia: A Systematic Review and Meta-analysis
Author: Zhang, Senlin; Wang, Qingwei; Cui, Kai; Cheng, Bingjie; Fan, Junjie; Hu, Shaoyan
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01266-7
-
Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers
Author: Yu, Xiangyou; Hao, Yan; Zhu, Zhanfang; Zhang, Wei; Liu, Bo; Ma, Meijuan; Zhang, Xuejun; Wei, Na; Wang, Junkui; Liu, Fuqiang
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01253-y
-
A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China
Author: Jiang, Yanqing; Liu, Ruizhe; Xuan, Jianwei; Lin, Sisi; Zheng, Qiang; Pang, Jianxin
Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01255-w
